Home › Funds › Shelton Emerging Markets Fund
Fund family: SCM Trust · Filed by SCM Trust (CIK 836267) · SEC series S000067906
Share classes and tickers: EMSLX (C000217722), EMSQX (C000217721)
“With management” counts the items where the fund’s own filing gives management’s recommendation (FOR or AGAINST): 535 with, 2 against, 1 abstentions (not counted as with management); 22 items carried no recommendation. Shareholder proposals: 2 FOR, 8 AGAINST, 0 abstained, by the filing’s own vote-source field.
No item-level comparison with other SCM Trust funds is possible: no ballot item of this fund was voted by at least three other funds of the family with a clear majority.
| Proposal type | Items | Against management |
|---|---|---|
| Corporate Governance | 181 | 1 |
| Director Elections | 156 | 0 |
| Capital Structure | 117 | 0 |
| Compensation | 64 | 1 |
| Audit-related | 29 | 0 |
| Extraordinary Transactions | 5 | 0 |
| Other | 5 | 0 |
| Shareholder Rights and Defenses | 2 | 0 |
| Other Social Issues | 1 | 0 |
Position = shares voted × a recent share price, for US-listed shares of companies with a page on this site; an estimate for ranking only.
| Company | Meeting | Est. position | Items | Against mgmt |
|---|---|---|---|---|
| Dr. Reddy's Laboratories Limited | July 24, 2025 | $940,800 | 6 | 0 |
| Infosys Limited | June 23, 2026 | $759,220 | 6 | 0 |
| Wipro Limited | July 16, 2025 | $146,229 | 4 | 0 |
| Wipro Limited | May 21, 2026 | $104,023 | 3 | 0 |
| Infosys Limited | November 4, 2025 | $2,169 | 1 | 0 |
| Meeting | Company | Proposal | Fund | Mgmt |
|---|---|---|---|---|
| March 26, 2026 | BNK Financial Group, Inc. | Approve Total Remuneration of Inside Directors and Outside Directors (Shareholder Proposal) Shareholder proposal | Against | For |
| March 26, 2026 | BNK Financial Group, Inc. | Approve Restricted Stock Unit Grant Details (Shareholder Proposal) Shareholder proposal | Against | For |
560 ballot items at 61 meetings in 2025-2026. Download all votes (CSV)
Recent votes against management’s recommendation at large companies.
In the 2025-2026 proxy season, Shelton Emerging Markets Fund (EMSLX) voted at 61 shareholder meetings of 48 companies, on 560 ballot items in all. Where management made a recommendation, the fund followed it on 99.4% of the items and voted against it 2 times. Its most frequent area of disagreement was corporate governance (1 of its votes against management). It voted on 10 shareholder proposals.
Every figure is derived from the fund’s own Form N-PX filings with the SEC, read item by item: one ballot item is the fund’s vote on one proposal at one meeting, and an item filed twice in the season is counted once. Percentages count items, never shares. A season is published only with at least 250 ballot items at 15 meetings. Built November 18, 2026. The interactive database shows the same votes company by company, with every other fund that voted.